NCT05710965 is a NA clinical trial of FRx-001 in ADHD, sponsored by Revibe Technologies.

Who is sponsoring NCT05710965?

NCT05710965 is sponsored by Revibe Technologies.

What drugs are being tested in NCT05710965?

Interventions in NCT05710965: FRx-001, FRx-003, FRx-004.

Is NCT05710965 still recruiting?

NCT05710965 is currently completed. Last updated 13 June 2023.

Last reviewed 2023-06-13 · How we verify

NCT05710965

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing a Wearable Digital Therapy for Youth With ADHD

Completed NA Last updated 13 June 2023

What this trial tests

NA trial testing FRx-001 in ADHD in 97 participants. Completed in 9 June 2023.

Timeline

15 February 2023

Primary endpoint
9 June 2023

9 June 2023

Quick facts

Lead sponsor	Revibe Technologies
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	97
Start date	15 February 2023
Primary completion	9 June 2023
Estimated completion	9 June 2023
Sites	1 location across United States

Drugs / interventions tested

FRx-001
FRx-003
FRx-004

Conditions studied

ADHD — all drugs for ADHD →

Sponsor

Revibe Technologies

Who can join

Adults 8 to 12, any sex, with ADHD. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to evaluate and compare three different investigational wearable digital interventions to determine if they are helpful for improving symptoms and functioning in children diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for ADHD

Currently open trials in the same condition.

NCT07314333 — A Trial to Assess How Centanafadine Interacts With Stimulants in the Body · Phase 1 · recruiting
NCT07262853 — Dual Executive Function Training Package · NA · recruiting
NCT07291453 — Loving Habits: A Feasibility Study of a Support Program for Building New Parent-child Behavioral Habits · NA · recruiting
NCT07281092 — Comparative Efficacy of Organizational Skills Training (OST) and Mindfulness-Based Intervention (MBI) · NA · recruiting
NCT07219810 — Accelerated iTBS Targeting of Working Memory Versus Inhibitory Control in Adolescent ADHD · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05710965 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Revibe Technologies
Last refreshed: 13 June 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05710965.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing